True Wealth Design’s Medline Inc MDLN Stock Holding History

True Wealth Design’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.42K	Buy	+36	New	+$1.45K	﹤0.01%	1853

Other funds holding MDLN

Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.66% 1-Year Est. Return

Robeco Institutional Asset Management

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Premier Fund Managers Guildford, United Kingdom $1.1B AUM 14.42% 1-Year Est. Return

IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.5B AUM 37.68% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Wellspring Financial Advisors Cleveland, Ohio $1.52B AUM 29.68% 1-Year Est. Return

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

True Wealth Design's MDLN Position: Q2 2026 in Review

True Wealth Design opened a new position in Medline Inc (MDLN) in Q2 2026: 36 shares worth $1.42K. The stake represents ﹤0.01% of the portfolio and ranks #1853 among its holdings.

45 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

True Wealth Design held 36 shares of Medline Inc worth $1.42K as of Q2 2026.
Medline Inc was a new True Wealth Design position in Q2 2026.
Medline Inc made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1853 holding.
45 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.